These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 466143)

  • 21. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
    Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
    Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial.
    Mattila E; Anttila VJ; Broas M; Marttila H; Poukka P; Kuusisto K; Pusa L; Sammalkorpi K; Dabek J; Koivurova OP; Vähätalo M; Moilanen V; Widenius T
    Scand J Infect Dis; 2008; 40(9):702-8. PubMed ID: 19086244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefotaxime-associated diarrhea and Clostridium difficile.
    Funada H; Ishizaki T; Kuroda T; Hattori K; Nakamura S
    Jpn J Antibiot; 1984 Apr; 37(4):555-7. PubMed ID: 6088823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of pseudomembranous colitis with oral metronidazole after relapse following vancomycin.
    Oldenburger D; Miller JA
    Am J Gastroenterol; 1980 Oct; 74(4):359-60. PubMed ID: 7457461
    [No Abstract]   [Full Text] [Related]  

  • 26. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.
    Bolton RP; Culshaw MA
    Gut; 1986 Oct; 27(10):1169-72. PubMed ID: 3781329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic-associated colitis.
    Pothoulakis H; Triadafilopoulos G; LaMont JT
    Compr Ther; 1985 Dec; 11(12):68-73. PubMed ID: 4075767
    [No Abstract]   [Full Text] [Related]  

  • 28. Fecal Microbiota Transplantation in Recurrent NAP1/B1/027 Clostridium Difficile Infection (CDI) Resistant to Vancomycin and Metronidazole in a Patient with Ulcerative Colitis (UC): A Case Report.
    Preda CM; Meianu C; Sandra I; Becheanu G; Dumbrava M; Manuc M; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):563-7. PubMed ID: 30044904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ; Murdoch DR
    Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract]   [Full Text] [Related]  

  • 30. Vancomycin "telephone".
    Drekonja DM
    Clin Infect Dis; 2011 Jul; 53(2):211-2. PubMed ID: 21690636
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile colitis.
    Trnka YM; Lamont JT
    Adv Intern Med; 1984; 29():85-107. PubMed ID: 6369936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomembranous colitis after topical application of clindamycin.
    Milstone EB; McDonald AJ; Scholhamer CF
    Arch Dermatol; 1981 Mar; 117(3):154-5. PubMed ID: 6452096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute arthritis associated with Clostridium difficile colitis.
    Bolton RP; Wood GM; Losowsky MS
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1023-4. PubMed ID: 6794747
    [No Abstract]   [Full Text] [Related]  

  • 35. Clostridium difficile-associated disease treatment response depends on definition of cure.
    Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
    Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
    [No Abstract]   [Full Text] [Related]  

  • 36. ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease.
    Am J Health Syst Pharm; 1998 Jul; 55(13):1407-11. PubMed ID: 9659970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis.
    Kurtz CB; Cannon EP; Brezzani A; Pitruzzello M; Dinardo C; Rinard E; Acheson DW; Fitzpatrick R; Kelly P; Shackett K; Papoulis AT; Goddard PJ; Barker RH; Palace GP; Klinger JD
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2340-7. PubMed ID: 11451694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrences in Clostridium difficile infections in cancer patients].
    García-Lozano T; Aznar-Oroval E; Martín-Utrilla S
    Med Clin (Barc); 2016 Nov; 147(9):417-418. PubMed ID: 27293195
    [No Abstract]   [Full Text] [Related]  

  • 39. Superimposed Clostridium difficile Infection During Checkpoint Inhibitor Immunotherapy-induced Colitis.
    Babacan NA; Tanvetyanon T
    J Immunother; 2019; 42(9):350-353. PubMed ID: 31107370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Approach to the treatment of intestinal infectious diseases caused by Clostridium difficile].
    Nyc O
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):93-6. PubMed ID: 20640987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.